Receptos Inc. Reaches All-Time High Amid Bidding Wars Between Gilead, Teva And AstraZeneca

Receptos Inc. (NASDAQ:RCPT) reached its all-time high during Friday's trading amid acquisition-related speculations. Evaluating the pipeline potential of the company and the demand for acquisitions in the pharmaceutical space, analysts raised the bid prices that can be expected to be placed for Receptos.